Incyte Corp (NASDAQ:INCY) over-valued by 9%
| Website | https://www.incyte.com/ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $17,969,909,760 |
| Beta | 0.801985 |
| Average Volume | $1,270,626 |
| Last Dividend | 0% |
| Price on Nov 1, 2022 | $76.95 |
| Autochartist™ Valuation | $70.40 |
| Conclusion |
9% over-valued |
| Download Report |
